Physician profile
Lucy Li
NPI 1164419701
$11,520.98
in general payments reported to CMS, 2019-2025
40 companies · $1,918 in 2025
The $1,918 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,828 · 2020: $1,161 · 2021: $1,253 · 2022: $1,958 · 2023: $1,574 · 2024: $1,829 · 2025: $1,918.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,319 · Education: $1.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,319.11 |
| Education | $1.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,677.96 | 2019-2025 | |
| Lilly USA, LLC | $1,455.70 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Novartis Pharmaceuticals Corporation | $1,149.39 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $1,119.93 | 2019-2025 | Ilumya, Absorica Ld, Winlevi |
| Regeneron Healthcare Solutions, INC. | $736.64 | 2019-2025 | Dupixent |
| Amgen INC. | $659.21 | 2020-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $601.32 | 2019-2025 | Nemluvio |
| Pfizer INC. | $548.48 | 2019-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $269.50 | 2019-2024 | Jublia, Arazlo, Cabtreo |
| Janssen Biotech, INC. | $245.03 | 2019-2021 | |
| Genzyme Corporation | $233.80 | 2019-2023 | |
| Leo Pharma INC. | $231.08 | 2020-2025 | Adbry, Anzupgo |
| Incyte Corporation | $208.12 | 2021-2025 | Opzelura |
| Strata Skin Sciences, INC. | $155.59 | 2023-2025 | Xtrac |
| E.R. Squibb & Sons, L.L.C. | $132.35 | 2022-2024 | Sotyktu |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucy Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.